GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 632 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $500,000 | -0.6% | 11,604 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $503,000 | +6.8% | 11,604 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $471,000 | -80.2% | 11,604 | -80.4% | 0.01% | -78.6% |
| Q4 2015 | $2,383,000 | +4.9% | 59,054 | 0.0% | 0.04% | +7.7% |
| Q3 2015 | $2,271,000 | -7.7% | 59,054 | 0.0% | 0.04% | +8.3% |
| Q2 2015 | $2,460,000 | -9.7% | 59,054 | 0.0% | 0.04% | -12.2% |
| Q1 2015 | $2,725,000 | +8.0% | 59,054 | 0.0% | 0.04% | +7.9% |
| Q4 2014 | $2,524,000 | -7.0% | 59,054 | 0.0% | 0.04% | -7.3% |
| Q3 2014 | $2,715,000 | -14.0% | 59,054 | 0.0% | 0.04% | -16.3% |
| Q2 2014 | $3,158,000 | +0.1% | 59,054 | 0.0% | 0.05% | -7.5% |
| Q1 2014 | $3,155,000 | +0.1% | 59,054 | 0.0% | 0.05% | +3.9% |
| Q4 2013 | $3,153,000 | +6.4% | 59,054 | 0.0% | 0.05% | 0.0% |
| Q3 2013 | $2,963,000 | +0.4% | 59,054 | 0.0% | 0.05% | -3.8% |
| Q2 2013 | $2,951,000 | – | 59,054 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |